Skip to Content

Logo 725 (Methylphenidate Hydrochloride Extended-Release 18 mg)

Pill with imprint Logo 725 is Yellow, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Actavis Pharma, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo 725

Methylphenidate hydrochloride extended-release 18 mg Logo 725

Methylphenidate Hydrochloride Extended-Release

Imprint
Logo 725
Strength
18 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
62037-0725

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.